GSK - GSK plc

NYSE - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 70.34B
Enterprise Value 87.65B
Trailing P/E 12.65
Forward P/E 9.21
PEG Ratio (5 yr expected) 1.31
Price/Sales (ttm)1.94
Price/Book (mrq)4.77
Enterprise Value/Revenue 3.01
Enterprise Value/EBITDA 10.15

Trading Information

Stock Price History

Beta (5Y Monthly) 0.28
52-Week Change 3-22.53%
S&P500 52-Week Change 32.72%
52 Week High 344.75
52 Week Low 328.47
50-Day Moving Average 336.05
200-Day Moving Average 334.19

Share Statistics

Avg Vol (3 month) 32.87M
Avg Vol (10 day) 32.79M
Shares Outstanding 52.05B
Implied Shares Outstanding 6N/A
Float 81.96B
% Held by Insiders 10.05%
% Held by Institutions 118.11%
Shares Short (May 14, 2023) 43.72M
Short Ratio (May 14, 2023) 41.39
Short % of Float (May 14, 2023) 4N/A
Short % of Shares Outstanding (May 14, 2023) 40.18%
Shares Short (prior month Apr 13, 2023) 43.4M

Dividends & Splits

Forward Annual Dividend Rate 41.39
Forward Annual Dividend Yield 44.12%
Trailing Annual Dividend Rate 30.58
Trailing Annual Dividend Yield 31.69%
5 Year Average Dividend Yield 45.23
Payout Ratio 456.35%
Dividend Date 3Jul 12, 2023
Ex-Dividend Date 4May 17, 2023
Last Split Factor 21226:1000
Last Split Date 3Jul 21, 2022

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023


Profit Margin 50.35%
Operating Margin (ttm)25.93%

Management Effectiveness

Return on Assets (ttm)6.36%
Return on Equity (ttm)28.17%

Income Statement

Revenue (ttm)29.08B
Revenue Per Share (ttm)14.42
Quarterly Revenue Growth (yoy)-3.30%
Gross Profit (ttm)19.92B
Net Income Avi to Common (ttm)4.46B
Diluted EPS (ttm)2.73
Quarterly Earnings Growth (yoy)-17.30%

Balance Sheet

Total Cash (mrq)6.98B
Total Cash Per Share (mrq)3.44
Total Debt (mrq)20.91B
Total Debt/Equity (mrq)184.80
Current Ratio (mrq)0.95
Book Value Per Share (mrq)5.83

Cash Flow Statement

Operating Cash Flow (ttm)4.91B
Levered Free Cash Flow (ttm)3.39B